[1] Smith GJ, Vijaykrishna D, Bahl J, et al.Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic[J]. Nature, 2009, 459(7250): 1122-1125. [2] Girard MP, Tam JS, Assossou OM, et al.The 2009 A (H1N1) influenza virus pandemic: A review[J]. Vaccine, 2010, 28(31): 4895-4902. [3] Sullivan SJ, Jacobson RM, Dowdle WR, et al.2009 H1N1 influenza[J]. Mayo Clin Proc, 2010, 85(1): 64-76. [4] Iuliano AD, Roguski KM, Chang HH, et al.Estimates of global seasonal influenza-associated respiratory mortality: A modelling study[J]. Lancet, 2018, 391(10127): 1285-1300. [5] Borgatta B, Pérez M, Rello J, et al.Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection[J]. Intensive Care Med, 2012, 38(7): 1152-1161. [6] Papic N, Pangercic A, Vargovic M, et al.Liver involvement during influenza infection: Perspective on the 2009 influenza pandemic[J]. Influenza Other Respir Viruses, 2012, 6(3): e2-e5. [7] Soo A, Zuege DJ, Fick GH, et al.Describing organ dysfunction in the intensive care unit: A cohort study of 20, 000 patients[J]. Critical Care, 2019, 23(1): 186. [8] Miller RR, Markewitz BA, Rolfs RT, et al.Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection[J]. Chest, 2010, 137(4): 752-758. [9] Mertz D, Kim TH, Johnstone J, et al.Populations at risk for severe or complicated influenza illness: Systematic review and meta-analysis[J]. BMJ, 2013, 347: f5061. [10] Álvarez-Lerma F, Marín-Corral J, Vila C, et al.Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome[J]. Critical Care, 2016, 20(1): 337. [11] Bagshaw SM, Sood MM, Long J, et al.Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: Cohort study[J]. BMC Nephrol, 2013, 14: 123. [12] Fullana Barceló MI, Artigues Serra F, Millan Pons AR, et al.Analysis of viral pneumonia and risk factors associated with severity of influenza virus infection in hospitalized patients from 2012 to 2016[J]. BMC Infect Dis, 2024, 24(1): 302. [13] Bassetti M, Parisini A, Calzi A, et al.Risk factors for severe complications of the novel influenza A (H1N1): Analysis of patients hospitalized in Italy[J]. Clin Microbiol Infect, 2011, 17(2): 247-250. [14] Carboni Bisso I, Prado E, Cantos J, et al.Influenza season 2019. Analysis of 143 hospitalized patients[J]. Medicina (B Aires), 2021, 81(3): 389-395. [15] Braga JU.Clinical predictors of severe forms of influenza A(H1N1)pdm09 in adults and children during the 2009 epidemic in Brazil[J]. PLoS One, 2024, 19(2): e0291843. [16] Casas-Aparicio GA, Leon-Rodriguez I, Hernandez-Zenteno RJ, et al.Aggressive fluid accumulation is associated with acute kidney injury and mortality in a cohort of patients with severe pneumonia caused by influenza A H1N1 virus[J]. PLoS One, 2018, 13(2): e0192592. [17] Chowell G, Ayala A, Berisha V, et al.Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010[J]. Comput Math Methods Med, 2012, 2012: 914196. [18] Chudasama RK, Patel UV, Verma PB, et al.Clinical and epidemiological characteristics of 2009 pandemic influenza A in hospitalized pediatric patients of the Saurashtra region, India[J]. World J Pediatr, 2012, 8(4): 321-327. [19] Cilloniz C, Ewig S, Menendez R, et al.Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia[J]. J Infect, 2012, 65(3): 223-230. [20] Damak H, Chtara K, Bahloul M, et al.Clinical features, complications and mortality in critically ill patients with 2009 influenza A(H1N1) in Sfax, Tunisia[J]. Influenza Other Respir Viruses, 2011, 5(4): 230-240. [21] Delgado C, Krotzsch E, Jimenez-Alvarez LA, et al.Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection[J]. Lung, 2015, 193(1): 25-30. [22] Deng LH, Zeng YL, Feng P, et al.Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China[J]. J Zhejiang Univ Sci B, 2012, 13(1): 49-55. [23] Dou M, Song W, Lin Y, et al.Clinical characteristics and viral analysis of severe influenza A[H1N1]pdm09 in Guangzhou, 2019[J]. J Med Virol, 2022, 94(6): 2568-2577. [24] Göya C, Yavuz A, Hamidi C, et al.The role of initial radiologic and clinical manifestations in predicting the prognosis for pneumonia caused by H1N1 influenza virus[J]. J Thorac Dis, 2014, 6(6): 752-759. [25] Hlavinkova L, Kristufkova Z, Mikas J.Risk factors for severe outcome of cases with pandemic influenza A(H1N1)pdm09[J]. Bratisl Lek Listy, 2015, 116(6): 389-393. [26] Hong SB, Choi EY, Kim SH, et al.Epidemiological analysis of critically ill adult patients with pandemic influenza A(H1N1) in South Korea[J]. Epidemiol Infect, 2013, 141(5): 1070-1079. [27] Iorio AM, Camilloni B, Basileo M, et al.An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy[J]. J Clin Med Res, 2013, 5(4): 286-293. [28] Jain S, Kamimoto L, Bramley AM, et al.Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009[J]. N Engl J Med, 2009, 361(20): 1935-1944. [29] Jamoussi A, Ayed S, Merhabene T, et al.Severe influenza A in a Tunisian ICU sentinel SARI centre: Epidemiological and clinical features[J]. PLoS One, 2022, 17(7): e0270814. [30] Kusznierz G, Uboldi A, Sosa G, et al.Clinical features of the hospitalized patients with 2009 pandemic influenza A (H1N1) in Santa Fe, Argentina[J]. Influenza Other Respir Viruses, 2013, 7(3): 410-417. [31] Lehners N, Geis S, Eisenbach C, et al.Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany[J]. Emerg Infect Dis, 2013, 19(5): 748-755. [32] Li SH, Hsieh MJ, Lin SW, et al.Outcomes of severe H1N1 pneumoniae: A retrospective study at intensive care units[J]. J Formos Med Assoc, 2020, 119(1): 26-33. [33] Lopez-Delgado JC, Rovira A, Esteve F, et al.Thrombocytopenia as a mortality risk factor in acute respiratory failure in H1N1 influenza[J]. Swiss Med Wkly, 2013, 143: w13788. [34] Louie JK, Acosta M, Samuel MC, et al.A novel risk factor for a novel virus: Obesity and 2009 pandemic influenza A (H1N1)[J]. Clin Infect Dis, 2011, 52(3): 301-312. [35] Lynfield R, Davey R, Dwyer DE, et al.Outcomes of influenza A(H1N1)pdm09 virus infection: Results from two international cohort studies[J]. PLoS One, 2014, 9(7): e101785. [36] Martin-Loeches I, Díaz E, Vidaur L, et al.Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients[J]. Crit Care, 2011, 15(6): R286. [37] Nateghian A, Gouya MM, Nabavi M, et al.Demographic, clinical, and virological characteristics of patients with a laboratory-confirmed diagnosis of influenza during three consecutive seasons, 2015/2016-2017/18, in the Islamic Republic of Iran[J]. J Clin Virol, 2020, 124: 104281. [38] Nermin KG, Remzi I, Zeynep A, et al.A retrospective evaluation of critically ill patients infected with H1N1 influenza A virus in Bursa, Turkey, during the 2009-2010 pandemic[J]. Afr Health Sci, 2015, 15(2). [39] Payet C, Lutringer-Magnin D, Cassier P, et al.Description of patients with confirmed influenza A(H1N1)pdm09 admitted to an intensive care unit and identification of severity risk factors[J]. Med Mal Infect, 2013, 43(2): 81-84. [40] Santa-Olalla PP, Cortes-García M, Vicente-Herrero M, et al.Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April-December 2009[J]. Euro Surveill, 2010, 15(38): 19667. [41] Pereira LA, Lapinscki BA, Santos JS, et al.Influenza A infections: Predictors of disease severity[J]. Braz J Microbiol, 2024, 55(1): 75-86. [42] Poeppl W, Hell M, Herkner H, et al.Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria[J]. Infection, 2011, 39(4): 341-352. [43] Ramakrishna K, Sampath S, Chacko J, et al.Clinical profile and predictors of mortality of severe pandemic (H1N1) 2009 virus infection needing intensive care: A multi-centre prospective study from South India[J]. J Glob Infect Dis, 2012, 4(3): 145-152. [44] Ren YY, Yin YY, Li WQ, et al.Risk factors associated with severe manifestations of 2009 pandemic influenza A (H1N1) infection in China: a case-control study[J]. Virol J, 2013, 10: 149. [45] Rovina N, Erifaki M, Katsaounou P, et al.Subjects hospitalized with the 2009 pandemic influenza A (H1N1) virus in a respiratory infection unit: clinical factors correlating with ICU admission[J]. Respir Care, 2014, 59(10): 1560-1568. [46] Schoen K, Horvat N, Guerreiro NFC, et al.Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity[J]. BMC Infect Dis, 2019, 19(1): 964. [47] Shah NS, Greenberg JA, McNulty MC, et al. Severe influenza in 33 US hospitals, 2013-2014: Complications and risk factors for death in 507 patients[J]. Infect Control Hosp Epidemiol, 2015, 36(11): 1251-1260. [48] Shi SJ, Li H, Liu M, et al.Mortality prediction to hospitalized patients with influenza pneumonia: PO(2) /FiO(2) combined lymphocyte count is the answer[J]. Clin Respir J, 2017, 11(3): 352-360. [49] Shimada T, Sunagawa T, Taniguchi K, et al.Description of hospitalized cases of influenza A(H1N1)pdm09 infection on the basis of the national hospitalized-case surveillance, 2009-2010, Japan[J]. Jpn J Infect Dis, 2015, 68(2): 151-158. [50] Snacken R, Quinten C, Devaux I, et al.Surveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010-2011[J]. Influenza Other Respir Viruses, 2012, 6(6): e93-e96. [51] Teke T, Coskun R, Sungur M, et al.2009 H1N1 influenza and experience in three critical care units[J]. Int J Med Sci, 2011, 8(3): 270-277. [52] Tekin S, Keske S, Alan S, et al.Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015-2016 season[J]. Int J Infect Dis, 2019, 81: 6-9. [53] To KK, Hung IF, Li IW, et al.Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection[J]. Clin Infect Dis, 2010, 50(6): 850-859. [54] Valenzuela-Mendez B, Valenzuela-Sanchez F, Rodriguez-Gutierrez JF, et al.Plasma levels of mid-regional proadrenomedullin accurately identify H1N1pdm09 influenza virus patients with risk of intensive care admission and mortality in the emergency department[J]. J Pers Med, 2022, 12(1): 84. [55] Verdier V, Lilienthal F, Desvergez A, et al.Severe forms of influenza infections admitted in intensive care units: Analysis of mortality factors[J]. Influenza Other Respir Viruses, 2023, 17(7): e13168. [56] Xu C, Iuliano AD, Chen M, et al.Characteristics of hospitalized cases with influenza A (H1N1)pdm09 infection during first winter season of post-pandemic in China[J]. PLoS One, 2013, 8(2): e55016. [57] Zarychanski R, Stuart TL, Kumar A, et al.Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection[J]. CMAJ, 2010, 182(3): 257-264. [58] Zhang YH, Zhao Y, Li N, et al.Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals[J]. Nat Commun, 2013, 4: 1418. [59] Zhou Y, Lau EH, Ip DK, et al.Years of life lost in the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong[J]. Am J Epidemiol, 2013, 178(8): 1313-1318. [60] Zhu L, Liu L, Zhang Y, et al.High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection[J]. J Infect Dis, 2018, 217(3): 428-437. [61] Zogheib E, Nyga R, Cornu M, et al.Prospective observational study on the association between serum mannose-binding lectin levels and severe outcome in critically ill patients with pandemic influenza type A (H1N1) infection[J]. Lung, 2018, 196(1): 65-72. [62] Pawelec G, Goldeck D, Derhovanessian E.Inflammation, ageing and chronic disease[J]. Current Opinion in Immunology, 2014, 29: 23-28. [63] Tran DD, Groeneveld AB, van der Meulen J, et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit[J]. Crit Care Med, 1990, 18(5): 474-479. [64] von der Beck D, Seeger W, Herold S, et al. Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data[J]. PLoS One, 2017, 12(7): e0180920. [65] Veerapandian R, Snyder JD, Samarasinghe AE.Influenza in asthmatics: For better or for worse?[J]. Front Immunol, 2018, 9: 1843. [66] Garg S, Jain S, Dawood FS, et al.Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008[J]. BMC Infect Dis, 2015, 15: 369. [67] Davoudi AR, Maleki AR, Beykmohammadi AR, et al.Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection[J]. Scand J Infect Dis, 2012, 44(6): 470-472. [68] Lin YH, Platt MP, Gilley RP, et al.Influenza Causes MLKL-Driven Cardiac Proteome Remodeling During Convalescence[J]. 2021, 128(5): 570-584. [69] Mukherjee A, Peterson JEG, Sandberg G, et al.Central nervous system pathology in fatal swine-origin influenza A H1N1 virus infection in patients with and without neurological symptoms: an autopsy study of 15 cases[J]. Acta Neuropathologica, 2011, 122(3): 371-373. [70] Gamboa ET, Eastwood AB, Hays AP, et al.Isolation of influenza virus from muscle in myoglobinuric polymyositis[J]. Neurology, 1979, 29(10): 1323-1335. [71] Abdulkader RC, Ho YL, de Sousa Santos S, et al. Characteristics of acute kidney injury in patients infected with the 2009 influenza A (H1N1) virus[J]. Clin J Am Soc Nephrol, 2010, 5(11): 1916-1921. [72] Ru YX, Li YC, Zhao Y, et al.Multiple organ invasion by viruses: Pathological characteristics in three fatal cases of the 2009 pandemic influenza A/H1N1[J]. Ultrastruct Pathol, 2011, 35(4): 155-161. |